Clinical Trial Update: A Multicenter Open Label Phase II Study of Pomalidomide and Cyclophosphamide and Dexamethasone in Relapse/Refractory Multiple Myeloma Patients Who Were First Treated Within the IFM/DFCI 2009 Trial (PCD) [Phase 2]

View source ↗

Summary

A multicenter open-label Phase II study evaluating pomalidomide, cyclophosphamide, and dexamethasone in relapsed/refractory multiple myeloma patients who were f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• DEXAMETHASONE (Dexamethasone)
• Pomalidomide (Pomalidomide)

Snippet

Sponsor: Institut Curie | Conditions: Multiple Myeloma, First Relapse | Phase 2 | Status: COMPLETED